catalyst · primary record
IZERVAY
Patent expiry · 2026-11-11 · AVACINCAPTAD PEGOL SODIUM
| Company | ASTELLAS PHARMA US INC |
|---|---|
| Ticker | Not stated |
| Impact | high |
| Detail | US 8236773 expires · AVACINCAPTAD PEGOL SODIUM |
| Source | FDA Orange Book |
Provenance
- Source: FDA Orange Book
- Fetched at: 2026-11-02T01:48:10.742Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: ASTELLAS PHARMA US INC:IZERVAY:2026-11-11:US 8236773 expires · AVACINCAPTAD PEGOL SODIUM
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.